Anticonvulsive Properties of Cannabidiol in a Model of Generalized Seizure Are Transient Receptor Potential Vanilloid 1 Dependent

Introduction: Highly purified cannabidiol (CBD) (approved as Epidiolex(®) in the United States) has demonstrated efficacy with an acceptable safety profile in patients with Lennox–Gastaut or Dravet syndrome in four randomized controlled trials. CBD possesses affinity for many target classes with fun...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Cannabis Cannabinoid Res
Main Authors: Gray, Royston A., Stott, Colin G., Jones, Nicholas A., Di Marzo, Vincenzo, Whalley, Benjamin J.
Formato: Artigo
Idioma:Inglês
Publicado: Mary Ann Liebert, Inc., publishers 2020
Assuntos:
Original Research
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC7347071/
https://ncbi.nlm.nih.gov/pubmed/32656346
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1089/can.2019.0028
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares